Mani Sharma

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 1 saleJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 1 buy · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€2,819

▼ Sales (1 ops.)

€1.9M

Latest filing published 08 Oct 2026 for AstraZeneca PLC, €285. Read the official filing

Filing timeline

BuySale

Mani Sharma

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

AstraZeneca PLC 1 purchase · last 11 Sept 2026

Mani Sharma: trading record in brief

This profile gathers the share dealings of Mani Sharma in AstraZeneca PLC. In total, 7 filings cover trades dated from 20 May 2026 to 6 October 2026.

In open-market terms, that means 1 purchase worth €2,819 on one side and 1 sale worth €1.9M on the other. Taken together, the sales exceed the purchases by €1.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants.

On 8 October 2026 came the latest disclosure, a share grant for €285 in AstraZeneca PLC. The last purchase on record was published on 11 September 2026, which is 36 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.